‘Bleach: Thousand-Year Blood War Part 2’: How to Stream Weekly From Anywhere

See at Hulu Get back into the drama when Bleach returns this season.  Tite Kubo/Shueisha,TV TOKYO, dentsu, Pierrot Summer is a wonderful time for anime fans. After months of waiting, Bleach: Thousand-Year Blood War is blazing across screens once again, following the first season’s cliff-hanger ending. The story returned on July 8 and continues to […]

Shepeard Community Blood Center collects blood for local deputy critically injured in the line of duty

AUGUSTA, Ga. (WJBF) – Shepeard Community Blood Center holding a blood drive in downtown Augusta to benefit a local deputy, who was critically injured in the line of duty.  The community showed up for Richmond County Sheriff’s Office Deputy Kenneth Mercer, who was shot after responding to a call on July 8th. Many donors said […]

Browns WR Goodwin (clots) to miss camp’s start

Jake Trotter, ESPN Staff WriterJul 21, 2023, 05:57 PM ET Close Jake Trotter covers the Cleveland Browns for ESPN. He joined ESPN in 2011 covering college football. Before that, he worked at The Oklahoman, Austin American-Statesman and Middletown (Ohio) Journal newspapers. You can follow him on Twitter @Jake_Trotter. BEREA, Ohio — Wide receiver Marquise Goodwin […]

Marquise Goodwin has blood clots in his legs and lungs

The Browns placed veteran receiver Marquise Goodwin on the non-football illness list Friday, and now we know why. Blood clots in his lungs and legs will force Goodwin to miss the start of training camp, the team announced. Goodwin, who is entering his 10th season, began experiencing discomfort in his legs and complained of shortness […]

Pfizer to end license deal with Syros for blood disorder therapies

Companies Pfizer Inc Follow Syros Pharmaceuticals Inc Follow July 21 (Reuters) – Syros Pharmaceuticals (SYRS.O) said on Friday Pfizer (PFE.N) will terminate a license deal between the companies related to the development of novel therapies for two blood disorders. Shares of Syros were down 5.7% in trading after the bell. The termination will end the […]

Permanent pacemakers after TAVR: Tracking the impact of modern self-expanding valves

Overall, PPI was required for 11.3% of TAVR patients within 30 days. This includes 8.8% of the 1,090 patients treated with the Acurate neo, 7.7% of the 665 patients treated with the Acurate neo2, 15.2% of the 1,312 patients treated with the Evolut Pro and 10.4% of the 144 patients treated with the Evolut Pro+. […]

Gilead Discontinues Study of Immunotherapy to Treat Blood Cancers

By Denny Jacob Gilead Sciences has discontinued its Phase 3 study of magrolimab in higher-risk myelodysplastic syndromes. The biopharmaceutical company said on Friday the study was discontinued due to futility based on a planned analysis. Gilead said it recommends discontinuing treatment with magrolimab in patients with myelodysplastic syndromes,…